We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+8.27%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$5.6B
AUM Growth
+$769M
(+16%)
Cap. Flow
+$469M
Cap. Flow
% of AUM
8.38%
Top 10 Holdings %
Top 10 Hldgs %
13.16%
Holding
1,266
New
125
Increased
352
Reduced
429
Closed
264
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$58.9M |
| 2 |
EOG Resources
EOG
|
+$37.7M |
| 3 |
Yum! Brands
YUM
|
+$29.2M |
| 4 |
Agilent Technologies
A
|
+$25.5M |
| 5 |
Occidental Petroleum
OXY
|
+$24.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gen Digital
GEN
|
+$27.1M |
| 2 |
Intercontinental Exchange
ICE
|
+$26M |
| 3 |
Global Payments
GPN
|
+$24.2M |
| 4 |
Cadence Design Systems
CDNS
|
+$22.8M |
| 5 |
Apple
AAPL
|
+$22.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.55% |
| 2 | Financials | 15.15% |
| 3 | Healthcare | 14.96% |
| 4 | Consumer Discretionary | 10.52% |
| 5 | Industrials | 10.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
Materion
MTRN
$5.01B
| $246K | ﹤0.01% |
8,010
-4,600
| -36% | -$129K |
|
852
Stewart Information Services
STC
$2.05B
| $245K | ﹤0.01% |
5,520
-1,900
| -26% | -$85.2K |
|
853
TransUnion
TRU
$14.8B
| $245K | ﹤0.01% |
+7,110
| New | +$238K |
|
854
First Busey Corp
BUSE
$2.52B
| $244K | ﹤0.01% |
10,806
-133
| -1% | -$3.06K |
|
|
DMTX
855
DELISTED
Dimension Therapeutics, Inc
DMTX
| $244K | ﹤0.01% |
30,500
+1,200
| +4% | +$8.68K |
|
|
CUTR
856
DELISTED
Cutera, Inc.
CUTR
| $242K | ﹤0.01% |
+20,335
| New | +$226K |
|
|
ALR
857
DELISTED
AlerisLife Inc
ALR
| $242K | ﹤0.01% |
12,651
-4,930
| -28% | -$105K |
|
|
RNWK
858
DELISTED
RealNetworks Inc
RNWK
| $242K | ﹤0.01% |
54,300
-3,000
| -5% | -$13.4K |
|
859
Spire
SR
$4.92B
| $241K | ﹤0.01% |
3,780
-170
| -4% | -$11.4K |
|
|
TCON
860
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
| $240K | ﹤0.01% |
180
-6
| -3% | -$6.76K |
|
|
BBRG
861
DELISTED
Bravo Brio Restaurant Group Inc.
BBRG
| $240K | ﹤0.01% |
50,229
-7,100
| -12% | -$42.7K |
|
|
MNI
862
DELISTED
The McClatchy Company Class A Common Stock
MNI
| $238K | ﹤0.01% |
14,781
-3,200
| -18% | -$53.8K |
|
|
BRKL
863
DELISTED
Brookline Bancorp
BRKL
| $235K | ﹤0.01% |
19,280
-46,892
| -71% | -$544K |
|
|
BGC
864
DELISTED
General Cable Corporation
BGC
| $235K | ﹤0.01% |
15,700
-188,458
| -92% | -$2.77M |
|
|
AE
865
DELISTED
Adams Resources & Energy Inc
AE
| $234K | ﹤0.01% |
5,944
-570
| -9% | -$20.1K |
|
|
ZAYO
866
DELISTED
Zayo Group Holdings, Inc.
ZAYO
| $234K | ﹤0.01% |
7,880
-2,590
| -25% | -$74.9K |
|
|
RNET
867
DELISTED
RigNet, Inc.
RNET
| $233K | ﹤0.01% |
15,399
-18,654
| -55% | -$238K |
|
868
Ezcorp Inc
EZPW
$1.82B
| $232K | ﹤0.01% |
21,000
| – | – |
|
869
First Business Financial Services
FBIZ
$562M
| $231K | ﹤0.01% |
9,830
-300
| -3% | -$6.94K |
|
|
HOUS
870
DELISTED
Anywhere Real Estate
HOUS
| $231K | ﹤0.01% |
8,940
| – | – |
|
871
Macerich
MAC
$7.32B
| $229K | ﹤0.01% |
2,830
-6,700
| -70% | -$566K |
|
872
ePlus
PLUS
$2.33B
| $229K | ﹤0.01% |
9,720
-17,080
| -64% | -$372K |
|
|
COVS
873
DELISTED
Covisint Corporation
COVS
| $229K | ﹤0.01% |
105,046
-30,596
| -23% | -$66.8K |
|
874
Oppenheimer Holdings
OPY
$1.17B
| $228K | ﹤0.01% |
15,953
-2,301
| -13% | -$35.8K |
|
|
DFS
875
DELISTED
Discover Financial Services
DFS
| $227K | ﹤0.01% |
+4,010
| New | +$230K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2016 Portfolio in Review
As of Q3 2016, Jacobs Levy Equity Management held 1,266 positions worth $5.6B, up 16% from $4.83B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jacobs Levy Equity Management deployed $469M of net new capital in Q3 2016, opening 125 new positions and adding to 352 existing holdings. Its largest new stake was Bristol-Myers Squibb: 916,932 shares worth $49.4M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Intercontinental Exchange, an estimated $26M trimmed.
- Jacobs Levy Equity Management's largest Q3 2016 buy was Bristol-Myers Squibb: 916,932 shares worth $49.4M.
- Jacobs Levy Equity Management added most to Agilent Technologies in Q3 2016, an estimated $25.5M increase.
- Jacobs Levy Equity Management's biggest Q3 2016 reduction was Intercontinental Exchange, cutting an estimated $26M.
- Jacobs Levy Equity Management fully exited Gen Digital in Q3 2016, selling an estimated $27.1M.
- Jacobs Levy Equity Management's ten largest holdings make up 13% of its $5.6B portfolio in Q3 2016.
- Jacobs Levy Equity Management opened 125 new positions and closed 264 in Q3 2016.
- Jacobs Levy Equity Management's portfolio value rose 16% quarter-over-quarter to $5.6B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2016, filed 14 Nov 2016.